These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9436639)

  • 1. Sodium valproate inhibits in vivo growth of human neuroblastoma cells.
    Cinatl J; Cinatl J; Driever PH; Kotchetkov R; Pouckova P; Kornhuber B; Schwabe D
    Anticancer Drugs; 1997 Nov; 8(10):958-63. PubMed ID: 9436639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor activity of sodium valproate in cultures of human neuroblastoma cells.
    Cinatl J; Cinatl J; Scholz M; Driever PH; Henrich D; Kabickova H; Vogel JU; Doerr HW; Kornhuber B
    Anticancer Drugs; 1996 Sep; 7(7):766-73. PubMed ID: 8949988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valproic acid and interferon-alpha synergistically inhibit neuroblastoma cell growth in vitro and in vivo.
    Michaelis M; Suhan T; Cinatl J; Driever PH; Cinatl J
    Int J Oncol; 2004 Dec; 25(6):1795-9. PubMed ID: 15547719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aphidicolin glycinate inhibits human neuroblastoma cell growth in vivo.
    Cinatl J; Cinatl J; Kotchetkov R; Driever PH; Bertels S; Siems K; Jas G; Bindseil K; Rabenau HF; Pouckova P; Doerr HW; Schwabe D
    Oncol Rep; 1999; 6(3):563-8. PubMed ID: 10203592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor activity of the selective MDM2 antagonist nutlin-3 against chemoresistant neuroblastoma with wild-type p53.
    Van Maerken T; Ferdinande L; Taildeman J; Lambertz I; Yigit N; Vercruysse L; Rihani A; Michaelis M; Cinatl J; Cuvelier CA; Marine JC; De Paepe A; Bracke M; Speleman F; Vandesompele J
    J Natl Cancer Inst; 2009 Nov; 101(22):1562-74. PubMed ID: 19903807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p21Waf1/Cip1 is a common target induced by short-chain fatty acid HDAC inhibitors (valproic acid, tributyrin and sodium butyrate) in neuroblastoma cells.
    Rocchi P; Tonelli R; Camerin C; Purgato S; Fronza R; Bianucci F; Guerra F; Pession A; Ferreri AM
    Oncol Rep; 2005 Jun; 13(6):1139-44. PubMed ID: 15870934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of differentiation and suppression of malignant phenotype of human neuroblastoma BE(2)-C cells by valproic acid: enhancement by combination with interferon-alpha.
    Cinatl J; Kotchetkov R; Blaheta R; Driever PH; Vogel JU; Cinatl J
    Int J Oncol; 2002 Jan; 20(1):97-106. PubMed ID: 11743648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valproic acid inhibits adhesion of vincristine- and cisplatin-resistant neuroblastoma tumour cells to endothelium.
    Blaheta RA; Michaelis M; Natsheh I; Hasenberg C; Weich E; Relja B; Jonas D; Doerr HW; Cinatl J
    Br J Cancer; 2007 Jun; 96(11):1699-706. PubMed ID: 17505515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of histone deacetylase inhibitor valproic acid on the anticancer effect of etoposide on neuroblastoma cells.
    Groh T; Hrabeta J; Poljakova J; Eckschlager T; Stiborova M
    Neuro Endocrinol Lett; 2012; 33 Suppl 3():16-24. PubMed ID: 23353839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valproic acid inhibits proliferation and changes expression of CD44 and CD56 of malignant glioma cells in vitro.
    Knüpfer MM; Hernáiz-Driever P; Poppenborg H; Wolff JE; Cinatl J
    Anticancer Res; 1998; 18(5A):3585-9. PubMed ID: 9858943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valproic Acid Increases CD133 Positive Cells that Show Low Sensitivity to Cytostatics in Neuroblastoma.
    Khalil MA; Hraběta J; Groh T; Procházka P; Doktorová H; Eckschlager T
    PLoS One; 2016; 11(9):e0162916. PubMed ID: 27627801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bovine seminal ribonuclease selectively kills human multidrug-resistant neuroblastoma cells via induction of apoptosis.
    Cinatl J; Cinatl J; Kotchetkov R; Vogel JU; Woodcock BG; Matousek J; Pouckova P; Kornhuber B
    Int J Oncol; 1999 Nov; 15(5):1001-9. PubMed ID: 10536185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valproic acid for the treatment of pediatric malignant glioma.
    Driever PH; Knüpfer MM; Cinatl J; Wolff JE
    Klin Padiatr; 1999; 211(4):323-8. PubMed ID: 10472571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arsenic trioxide inhibits neuroblastoma growth in vivo and promotes apoptotic cell death in vitro.
    Ora I; Bondesson L; Jönsson C; Ljungberg J; Pörn-Ares I; Garwicz S; Pâhlman S
    Biochem Biophys Res Commun; 2000 Oct; 277(1):179-85. PubMed ID: 11027660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticancer agent ellipticine combined with histone deacetylase inhibitors, valproic acid and trichostatin A, is an effective DNA damage strategy in human neuroblastoma.
    Poljakova J; Hrebackova J; Dvorakova M; Moserova M; Eckschlager T; Hrabeta J; Göttlicherova M; Kopejtkova B; Frei E; Kizek R; Stiborova M
    Neuro Endocrinol Lett; 2011; 32 Suppl 1():101-16. PubMed ID: 22167207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The synergistic effects of DNA-damaging drugs cisplatin and etoposide with a histone deacetylase inhibitor valproate in high-risk neuroblastoma cells.
    Groh T; Hrabeta J; Khalil MA; Doktorova H; Eckschlager T; Stiborova M
    Int J Oncol; 2015 Jul; 47(1):343-52. PubMed ID: 25963435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bovine seminal ribonuclease inhibits in vivo growth of human neuroblastoma cells.
    Kotchetkov R; Cinatl J; Matousek J; Vogel J; Pouckova P; Wagner M; Kornhuber B; Schwabe D; Cinatl J
    Oncol Rep; 2000; 7(2):363-7. PubMed ID: 10671687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of the angiogenesis inhibitor TNP-470 in reducing the growth of human neuroblastoma in nude mice inversely correlates with tumor burden.
    Katzenstein HM; Rademaker AW; Senger C; Salwen HR; Nguyen NN; Thorner PS; Litsas L; Cohn SL
    Clin Cancer Res; 1999 Dec; 5(12):4273-8. PubMed ID: 10632370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of resistance to vincristine and doxorubicin in neuroblastoma alters malignant properties and induces additional karyotype changes: a preclinical model.
    Kotchetkov R; Cinatl J; Blaheta R; Vogel JU; Karaskova J; Squire J; Hernáiz Driever P; Klingebiel T; Cinatl J
    Int J Cancer; 2003 Mar; 104(1):36-43. PubMed ID: 12532417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valproic acid suppresses Warburg effect and tumor progression in neuroblastoma.
    Fang E; Wang J; Hong M; Zheng L; Tong Q
    Biochem Biophys Res Commun; 2019 Jan; 508(1):9-16. PubMed ID: 30466785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.